Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Immune Checkpoint Inhibitors × Clear all

Phase

Status

Completed 6 Unknown 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 11 Carcinoma, Hepatocellular 6 Esophageal Neoplasms 5 Triple Negative Breast Neoplasms 4 Neoplasm Metastasis 4 Nasopharyngeal Carcinoma 4 Advanced NSCLC 4 Stomach Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Melanoma 3 Small Cell Lung Carcinoma 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Solid Cancers 1 Small Cell Lung Cancer Extensive Stage 1 Sjogren's Syndrome 1 Scleroderma, Systemic 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma 1 SCLC 1 Rhabdomyosarcoma 1

Interventions

pembrolizumab 31 Blood Specimen Collection 29 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 14 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Cisplatin 11 atezolizumab 10 Drug Therapy 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 9 Pemetrexed 8 Fluorouracil 8 olaparib 7 Trastuzumab 7 Temozolomide 7 Leucovorin 7 Irinotecan 7 Interviews as Topic 7 Cetuximab 7 pertuzumab 6 Radiosurgery 6 Panitumumab 6 Oxaliplatin 6 Observation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06524570 2026-02-18

iFOCUS

UMC Utrecht

Phase 1 Recruiting

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡